XtalPi’s AI biologics discovery platform licensed to Janssen Biotech
XtalPi, an AI drug discovery company and subsidiary of Ailux Biologics, has entered a licensing agreement with Janssen Biotech, a…
Company News
Booster Therapeutics to develop proteasome activator medicines
KeyBioscience and Eli Lilly extend partnership for obesity treatments
Merck unveils $318m biosafety testing facility in Maryland, US
Arda Therapeutics secures $43m to develop cell depletion therapies
Boehringer and Circle Pharma link to develop new cancer treatment
MSD ventures into fibroblast therapies with $1.9bn deal with Mestag
FDA declines to approve Zealand Pharma’s hypoglycaemia therapy in infants
